Attached files
EXHIBIT 99
GREENWOOD VILLAGE, CO --(Marketwired - April 28, 2015) - Greenhouse Solutions
Inc. (OTC PINK: GRSU) today announced the addition of Kevin Kjernisted, M.D. to
the company's advisory board. Dr. Kjernisted is a Clinical Associate Professor
at The University of British Columbia where he specializes in clinical
psychiatry. He will join the Senior Advisors that Greenhouse Solutions has been
assembling. The addition of Dr. Kjernisted is intended to advance the Company's
efforts in the emerging CBD (Cannabidol) nutraceutical field as well as the
potential for creating further intellectual property for products incorporating
CBDs.
"I am excited to announce the addition of Kevin Kjernisted to our Advisory
Board," commented Rik J. Deitsch, CEO of Greenhouse Solutions. "When I joined
Greenhouse Solutions back in January, I believed we had a plan in place that
would allow us to attract scientists and physicians to help cultivate our
company. The addition of Dr. Kjernisted to our team further supports Greenhouse
Solutions efforts to bring solutions to the cannabis marketplace," he continued.
"We believe we have now added another vital piece to the puzzle that will allow
Greenhouse Solutions to accelerate our growth in the coming months and fulfill
our goals to work within this field as well as to be the 'go to company' for the
dozens of other players trying to make their way in the lucrative cannabis
market," he concluded.
Dr. Kevin Kjernisted received his Medical Degree from the University of Manitoba
in 1983. He worked as a general practitioner for 5 years before completing
training to be a psychiatrist at the University of Manitoba. For more than a
decade Dr. Kjernisted was Medical Director of the Anxiety Disorders Clinic and
Director of Research at St. Boniface General Hospital in the Department of
Psychiatry, University of Manitoba before relocating to Vancouver, Canada where
he is currently a Clinical Associate Professor of Psychiatry in the Faculty of
Medicine at the University of British Columbia. Dr. Kjernisted has acted as
principal investigator in over 35 clinical trials investigating compounds for
mood disorders, anxiety disorders, schizophrenia, ADHD and weight management.
His research interests also include the "mind-body connection" which involves
interactions between the brain, the gut and the immune system
(psychoneuroimmunology). Dr. Kjernisted has lectured extensively on this topic
to peers at national and international meetings. Optimal treatment in his busy
clinical practice involves complementary and alternative treatments including
probiotics, exercise and nutraceuticals, along with medications and
psychotherapy, in order to address excessive inflammation and oxidation which
contribute to psychiatric illness, chronic pain, heart disease, liver disease,
diabetes, inflammatory bowel disease, cancer and dementia.
"I look forward to working with such a knowledgeable and experienced team of
professionals," stated Kevin Kjernisted M.D. FRCPC. "I am particularly impressed
by their dedication to the importance of safety, quality control and
standardization in the development and preparation of these products," he
concluded.
About Greenhouse Solutions, Inc.?Greenhouse Solutions operates three distinct
business units within the burgeoning cannabis market: Greenhouse Solutions'
Design & Consulting Serviceoffers an all-inclusive solution to the expansion and
efficiency of hydroponic and agricultural businesses nationwide. The Company is
able to supply a comprehensive solution to the design, build, implementation,
production, and expansion of all variations of indoor, outdoor and greenhouse
agricultural business; Greenhouse Solutions' Product Developmentdevelops,
markets, produces and sells cannabidiol ("CBD") products for both the personal
health and companion pet markets utilizing a licensed probiotic delivery system
(US Patent #6,080,401) and other licensed formulas. Cannabidiol (CBD) is a
naturally-occurring substance found in both the cannabis and hemp species of the
Cannabis Sativa plant; and Growhouse Solutionsacts as a distributor for a
variety of equipment, supplies and nutrients for the growhouse industry. We
encourage all current and prospective shareholders to visit our website at:
http://www.greenhousesolutionsinc.com
SEC Disclaimer?This press release contains forward-looking statements. The words
or phrases "would be," "will allow," "intends to," "will likely result," "are
expected to," "will continue," "is anticipated," "estimate," "project," or
similar expressions are intended to identify "forward-looking statements."
Actual results could differ materially from those projected in Greenhouse
Solutions' ("the Company's") business plan. The addition of Dr. Kjernisted to
our Advisory Board should not be construed as an indication in any way
whatsoever of the future value of the Company's common stock or its present or
future financial condition. The Company's filings may be accessed at the SEC's
Edgar system at www.sec.gov. Statements made herein are as of the date of this
press release and should not be relied upon as of any subsequent date. The
Company cautions readers not to place reliance on such statements. Unless
otherwise required by applicable law, we do not undertake, and we specifically
disclaim any obligation, to update any forward-looking statements to reflect
occurrences, developments, unanticipated events or circumstances after the date
of such statement.
Contact:
Greenhouse Solutions, Inc.
investors@greenhousesolutionsinc.com
www.greenhousesolutionsinc.com
1-877-521-239
